Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

2.

Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.

Brouns R, De Vil B, Cras P, De Surgeloose D, Mariën P, De Deyn PP.

Clin Chem. 2010 Mar;56(3):451-8. doi: 10.1373/clinchem.2009.134122. Epub 2009 Dec 3.

3.

Biochemical markers of cerebrospinal ischemia after repair of aneurysms of the descending and thoracoabdominal aorta.

Anderson RE, Winnerkvist A, Hansson LO, Nilsson O, Rosengren L, Settergren G, Vaage J.

J Cardiothorac Vasc Anesth. 2003 Oct;17(5):598-603.

PMID:
14579213
4.

Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.

Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, D'Avila TT, Souza DO, Portela LV, Stefani MA.

Neurosurgery. 2011 Jun;68(6):1624-30; discussion 1630-1. doi: 10.1227/NEU.0b013e318214a81f.

PMID:
21368691
5.

Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.

Beems T, Simons KS, Van Geel WJ, De Reus HP, Vos PE, Verbeek MM.

Acta Neurochir (Wien). 2003 Jan;145(1):37-43.

PMID:
12545260
6.

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.

Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM.

Neurology. 2004 Apr 27;62(8):1303-10.

PMID:
15111666
7.

The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.

Moritz S, Warnat J, Bele S, Graf BM, Woertgen C.

J Neurosurg Anesthesiol. 2010 Jan;22(1):21-31. doi: 10.1097/ANA.0b013e3181bdf50d.

PMID:
20027011
8.

Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.

Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM.

Pediatrics. 2002 Feb;109(2):E31.

PMID:
11826241
9.

Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.

Baker AJ, Rhind SG, Morrison LJ, Black S, Crnko NT, Shek PN, Rizoli SB.

J Neurotrauma. 2009 Aug;26(8):1227-40. doi: 10.1089/neu.2008.0868.

PMID:
19637968
10.

Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome.

Fujii C, Tokuda T, Ishigami N, Mizuno T, Nakagawa M.

Neurosci Lett. 2011 Apr 20;494(1):86-8. doi: 10.1016/j.neulet.2011.02.063. Epub 2011 Mar 1.

PMID:
21371524
11.

Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.

Petzold A, Eikelenboom MJ, Gveric D, Keir G, Chapman M, Lazeron RH, Cuzner ML, Polman CH, Uitdehaag BM, Thompson EJ, Giovannoni G.

Brain. 2002 Jul;125(Pt 7):1462-73.

12.

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.

Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM.

J Neurosurg. 2005 Jul;103(1 Suppl):61-8.

PMID:
16122007
13.

Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration?

Yilmaz N, Karaali K, Ozdem S, Turkay M, Unal A, Dora B.

Cell Mol Neurobiol. 2011 May;31(4):579-85. doi: 10.1007/s10571-011-9651-z. Epub 2011 Feb 4.

PMID:
21293918
14.

Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica.

Brisby H, Olmarker K, Rosengren L, Cederlund CG, Rydevik B.

Spine (Phila Pa 1976). 1999 Apr 15;24(8):742-6.

PMID:
10222523
15.

Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.

Undén J, Strandberg K, Malm J, Campbell E, Rosengren L, Stenflo J, Norrving B, Romner B, Lindgren A, Andsberg G.

J Neurol. 2009 Jan;256(1):72-7. doi: 10.1007/s00415-009-0054-8. Epub 2009 Feb 9.

PMID:
19221847
16.

Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis.

Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE.

Psychiatry Res. 2009 May 15;167(1-2):66-72. doi: 10.1016/j.psychres.2008.01.002. Epub 2009 Apr 16.

PMID:
19375171
17.

Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.

Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, Fujita M, Izumi T, Maekawa T.

J Trauma. 2010 Jul;69(1):104-9. doi: 10.1097/TA.0b013e3181bbd485.

PMID:
20093985
18.

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.

Malmeström C, Haghighi S, Rosengren L, Andersen O, Lycke J.

Neurology. 2003 Dec 23;61(12):1720-5.

PMID:
14694036
19.

Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning.

Yardan T, Cevik Y, Donderici O, Kavalci C, Yilmaz FM, Yilmaz G, Vural K, Yuzbasioglu Y, Gunaydin YK, Sezer AA.

Am J Emerg Med. 2009 Sep;27(7):838-42. doi: 10.1016/j.ajem.2008.04.016.

PMID:
19683113
20.

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.

Takano R, Misu T, Takahashi T, Sato S, Fujihara K, Itoyama Y.

Neurology. 2010 Jul 20;75(3):208-16. doi: 10.1212/WNL.0b013e3181e2414b.

PMID:
20644148
Items per page

Supplemental Content

Write to the Help Desk